UNI-EN 64:Current report 64 re insiders transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 64 | / | 2014 | | ||||||
| Date of issue: | 2014-06-18 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Current report 64 re insiders transactions | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Donev Investments Holding AD" related to him, executed the following transactions related to shares in the Company: Date and time Operation Number Unit price of the of (BGN) settlement shares 09.06.2014 Buy 500 4.390 09.06.2014 Buy 310 4.375 09.06.2014 Buy 150 4.375 09.06.2014 Buy 19 4.375 10.06.2014 Buy 100 4.440 10.06.2014 Buy 72 4.370 10.06.2014 Buy 286 4.370 10.06.2014 Buy 142 4.370 10.06.2014 Buy 228 4.350 10.06.2014 Buy 272 4.350 11.06.2014 Buy 200 4.360 12.06.2014 Buy 80 4.400 12.06.2014 Buy 200 4.420 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report 64 re insiders transactions.doc Current report 64 re insiders transactions.doc | Current report 64 re insiders transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2014-06-18 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.0 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
